Characterization of Flexusin A, a Novel Circular Bacteriocin Produced by Marine Bacterium Bacillus flexus R29-2
Marine Drugs · 21.02.2025 · 23 (3) · 95
DOI: 10.3390/md23030095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 21.02.2025. Verfasst von Xiaoni Qiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China. Hauptthemen laut MEDLINE: Bacteriocins, Anti-Bacterial Agents, Bacillus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TaiShan Industrial Experts Program, the Special Fund for TaiShan Industrial Experts Program, Science and Technology Department of Shandong Province, China.
Abstract (Originalsprache)
Circular bacteriocins are potent antimicrobials against pathogenic Gram-positives. In searching for marine bacteriocins, an antibacterial peptide (flexusin A) was purified from the fermentation broth of marine bacterium Bacillus flexus R29-2. Genome sequencing and gene annotation revealed the chromosome contained an unknown circular bacteriocin gene cluster. Approaches including shot-gun proteomics analysis, AntiSMASH and BAGEL4 predication as well as the comprehensive sequence alignment, were then conducted, respectively, to verify the correlation of flexusin A with the gene-encoded precursor peptide. The results confirmed that flexusin A was the mature circular bacteriocin of the predicated precursor peptide with six amino acids as leader peptide. Flexusin A was 6098.4 Da in size, with a net charge of +3 and PI of 9.60. It shared the typical saposin-like fold spatial conformation features as commonly found in other circular bacteriocins. Flexusin A was pH, thermal, and protease tolerant. It exhibited a narrow antimicrobial spectrum against Gram-positives, and it can strongly inhibit Staphylococcus aureus by causing cell destruction via membrane destabilization. Taken together, a novel circular bacteriocin flexusin A was identified in this work. The characterization of flexusin A has extended circular bacteriocins family to 26 members. This is also the first report on bacteriocin production by B. flexus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
- Qingdao Bioantai Biotechnology Co., Ltd., Qingdao 266000, China.
- State Key Laboratory of Animal Nutrition, Institute of Animal Sciences of Chinese Academy of Agricultural Sciences, Beijing 100193, China.
- Marine Microbial Engineering Research and Development Center, Marine Biomedical Research Institute of Qingdao, Qingdao 266071, China.
ORCID-Profile: Wei Tang, Zengguo He
Förderung
- TaiShan Industrial Experts Program
- the Special Fund for TaiShan Industrial Experts Program, Science and Technology Department of Shandong Province, China
Zitieren
APA
Qiao, X., Sun, X., Wang, S., Zhai, C., Tang, W., Tang, T., Zhang, J., & He, Z. (2025). Characterization of Flexusin A, a Novel Circular Bacteriocin Produced by Marine Bacterium Bacillus flexus R29-2. Marine Drugs, 23(3), 95. https://doi.org/10.3390/md23030095
Vancouver
Qiao X, Sun X, Wang S, Zhai C, Tang W, Tang T, et al. Characterization of Flexusin A, a Novel Circular Bacteriocin Produced by Marine Bacterium Bacillus flexus R29-2. Marine Drugs. 2025;23(3):95. doi:10.3390/md23030095
BibTeX
@article{Qiao2025,
author = {Qiao, Xiaoni and Sun, Xiaowen and Wang, Shuting and Zhai, Chen and Tang, Wei and Tang, Tao and Zhang, Jun and He, Zengguo},
title = {Characterization of Flexusin A, a Novel Circular Bacteriocin Produced by Marine Bacterium Bacillus flexus R29-2},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {3},
pages = {95},
doi = {10.3390/md23030095}
}
EUVIMED